Citi Maintains a 'Buy' Rating on Brightpoint Inc (CELL); First Look: Significantly Better than Expected
Tweet Send to a Friend
Citi maintains a 'Buy' rating on Brightpoint Inc (Nasdaq: CELL), price target $10.
Citi analyst highlights Pros and Cons:
Positives ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst highlights Pros and Cons:
Positives ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
